Procalcitonin as a marker of bacterial infection in elderly patients
More details
Hide details
Dept of Pneumonology, Medical School, Democritus University of Thrace, Greece
Corresponding author
Demosthenes Bouros   

Dept. of Pneumonology, Medical School, Democritus University of Thrace, Alexandroupolis 68100, Greece
Pneumon 2014;27(1):13–15
Muller B, White JC, Nylen ES, et al. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001;86:396-404.
Jensen JU, Heslet L, Jensen TH, et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006;34:2596-2602.
Christ-Crain M, Muller B. Procalcitonin in bacterial infections- hype, hope, more or less? Swiss Med Wkly, 2005;135(31- 32):451-460.
Muller B, Peri G, Doni A, et al. High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration. J Leukoc Biol 2002;72:643-649.
de Kruif LL, Giebelen IA, Struck J, et al. The influence of corticosteroids on the release of novel biomarkers in human endotoxemia. Intensive Care Med 2008;34:518-522.
Schuetz P, Chiappa V, Briel M, et al. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011;171:1322-1331.
Schuetz P, Muller B, Christ-Crain M, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev, 2012. 9: p. CD007498.
Ackermann RJ, Monroe PW. Bacteremic urinary tract infection in older people. J Am Geriatr Soc 1996;44:927-933.
Lee CC, IJ Chang, YC Lai, et al. Epidemiology and prognostic determinants of patients with bacteremic cholecystitis or cholangitis. Am J Gastroenterol 2007;102:563-569.
Gutierrez F, Masia M. Improving outcomes of elderly patients with community-acquired pneumonia. Drugs Aging 2008;25: 585-610.
Fernandez-Sabe N, Carratala J, Roson B, et al. Communityacquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine (Baltimore), 2003;82:159-69.
Lee CC, Chen SY, Chang IJ, et al, Comparison of clinical manifestations and outcome of community-acquired bloodstream infections among the oldest old, elderly, and adult patients. Medicine (Baltimore), 2007;86:138-44.
van Duin D. Diagnostic challenges and opportunities in older adults with infectious diseases. Clin Infect Dis 2012;54:973-978.
Caterino JM, Scheatzle MD, Forbes ML, et al. Bacteremic elder emergency department patients: procalcitonin and white count. Acad Emerg Med 2004;11:393-396.
Lai CC, Chen SY, Wang CY, et al. Diagnostic value of procalcitonin for bacterial infection in elderly patients in the emergency department. J Am Geriatr Soc 2010;58:518-522.
Steichen O, Bouvard E, Grateau G, et al. Diagnostic value of procalcitonin in acutely hospitalized elderly patients. Eur J Clin Microbiol Infect Dis 2009;28:1471-1476.
Stucker F, Herrmann F, Graf JD, et al. Procalcitonin and infection in elderly patients. J Am Geriatr Soc 2005;53:1392-1395.
Dwolatzky T, Olshtain-Pops K, Yinnon AM, et al. Procalcitonin in the elderly: normal plasma concentrations and response to bacterial infections. Eur J Clin Microbiol Infect Dis 2005;24:763- 765.
Lee SH, Chan RC, Wu JY, et al. Diagnostic value of procalcitonin for bacterial infection in elderly patients - a systemic review and meta-analysis. Int J Clin Pract 2013;67:1350-1357.
Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis, 2004;39:206- 217.